Skip to site menu Skip to page content

Daily Newsletter

03 November 2023

Daily Newsletter

03 November 2023

MSF concludes medical activities at Iraq’s Sinuni General Hospital

MSF transferred mental healthcare services to the International Organization for Migration.

November 03 2023

Humanitarian medical care provider Médecins Sans Frontières (MSF) has completed medical activities at Sinuni General Hospital in Sinjar, Iraq, after a five-year effort to restore healthcare services in the region.

Sinuni, a town in the Ninewa governorate, had been under the control of the Islamic State (IS) group since 2014, resulting in extreme violence, particularly against the Yazidi community.

MSF started its work at Sinuni General Hospital in August 2018, with the goal of rehabilitating the hospital, providing maternity services, emergency medical care, and care for children and newborns.

The functioning hospital encouraged people to return to the area after the battle to retake the Sinjar district.

MSF also recognised the psychological trauma suffered by the Yazidi community and introduced comprehensive mental health services, offering counselling, psychological support, and psychiatric care, both within the hospital and the community.

In addition, MSF expanded its services by setting up an isolation unit to treat Covid-19 patients in 2022.

Throughout its time in Sinuni, MSF focused on building local healthcare capacity and providing training for healthcare professionals.

In September 2021, MSF handed over the maternity and paediatric departments to the Ninewa Directorate of Health and, in January 2023, it transitioned all remaining responsibilities to local health authorities.

By the end of October 2023, mental health care services were handed over to the International Organization for Migration (IOM), and the rest of MSF's activities were transferred to the Ninewa Directorate of Health.

Is the healthcare industry ready to fully embrace the benefits of digitalization and AI?

The healthcare, pharma, and medical devices industries are often risk-averse compared to other sectors when adopting new technologies. However, mainly due to COVID-19, these sectors have witnessed an acceleration in digital transformation. AI can revolutionize the drug discovery process and significantly reduce the time and cost to get a drug to market, particularly in areas of unmet need. There is also huge potential for AI in medical diagnostics. However, using healthcare data for AI development raises data privacy concerns, thereby limiting its adoption.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close